Fang Li

Circulating tumor DNA-minimal residual disease: an up-and-coming nova in resectable non-small-cell lung cancer.

J. Cui, Fang Li, 2022, Critical reviews in oncology/hematology.

Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy

Yong Song, Ming Liu, Chengzhi Zhou, 2021, Frontiers in Immunology.

Complex genetic alterations contribute to rapid disease progression in an ALK rearrangement lung adenocarcinoma patient: a case report

Hao Wu, Min Zhang, Chenglin Yang, 2021, Translational cancer research.

Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study

Yuhua Gong, S. Dong, Wenjie Zhong, 2023, Molecular oncology.

Circulating tumor DNA analysis detects micrometastatic disease and predicts recurrence in a patient with colon cancer: A case report

Bo Zhou, Cheng-yuan Qian, Liang Zhao, 2023, Medicine.

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer

Yuhua Gong, Rongrong Chen, Pengli Yu, 2024, Therapeutic advances in medical oncology.